JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
TGTX Financials - Tg Therapeutics Income & Cash Flow | Ledgeburg
TGTX - Tg Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary TGTX Stock
Financials
Financials TGTX Stock
Loading...
Loading...
Income Statement
Income Statement TGTX Stock
Balance Sheet
Balance Sheet TGTX Stock
Cash Flow Statement
Cash Flow Statement TGTX Stock
Loading...
Loading...
Home
Stocks
Tg Therapeutics, Inc. (TGTX)
Financials
Financials of TGTX
Loading...
Loading...
Loading...
Loading...
Revenue
$616.287M
Operating Income
$123.324M
Net Income
$447.179M
Share Count (Basic)
144.316786M
Operating Cash Flow
$-24.772M
Free Cash Flow
$-24.986M
Cash And Short-Term Equivalents
$141.97M
Total Debt
$245.645M
Annual
Quarterly
Revenue $USD
0
200M
400M
600M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
50M
100M
150M
200M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-400M
-200M
0
200M
400M
Annual
Quarterly
Margins
Gross
Operating
Net
-8000%
-6000%
-4000%
-2000%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
0
100M
200M
300M
400M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
0%
50%
100%
150%
200%
250%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26